FDA Approved: SUMATRIPTAN AND NAPROXEN SODIUM — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for Sumatriptan and Naproxen Sodium by NorthStar RxLLC. The product is indicated for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• SUMATRIPTAN AND NAPROXEN SODIUM (Sumatriptan and Naproxen Sodium)

Snippet

SUPPL AP for SUMATRIPTAN AND NAPROXEN SODIUM (SUMATRIPTAN AND NAPROXEN SODIUM)